All
Multiple modalities enable successful treatment of atopic dermatitis in children
September 1st 2012Topical corticosteroids are still the mainstay of therapy for pediatric atopic dermatitis (AD), but dermatologists have an array of other options at their disposal to use for steroid sparing or in challenging situations.
Physicians take critical look at AJCC staging system, melanoma prognostication tool
September 1st 2012The latest melanoma staging system from the American Joint Committee on Cancer (AJCC) and a tool developed for predicting the clinical outcome of individual patients with localized or regional cutaneous melanoma (www.melanomaprognosis.org) have stirred debate among dermatopathologists.
Skin cancer diagnosis spurs congressman to advocate for more research, funding
September 1st 2012Dermatology has a committed ambassador in Capitol Hill, but it's tragic as to why. Rep. Brian Bilbray (R-Calif.) and his youngest daughter, Briana, both have been diagnosed with skin cancer and are speaking out about it to encourage others to prevent and detect skin cancer early. The congressman has co-sponsored the Melanoma Research Act of 2012, which would provide funding for skin cancer research.
Make outsourcing work optimally for you and your medical practice
September 1st 2012A dermatology practice is a hotbed of activity. In addition to the clinical care you provide, there is staff to manage in carrying out your orders, supplies to use, bills to be sent and money to be tracked. The complexity of a practice makes outsourcing - using outside firms to handle work you would normally perform in-house - appear quite appealing.
Optimize outcomes in patients with skin of color by tailoring therapies
September 1st 2012When treating patients with skin of color, dermatologists face a number of challenges, and they must choose products and therapies carefully. Diagnosis is the first challenge; common dermatological conditions may have a slightly different appearance in skin of color, depending on the hue of a patient's skin, says Charles Crutchfield III, M.D.
App to connect acne patients with dermatologists
August 22nd 2012Patients with acne looking for a dermatologist may not have to go much farther than the nearest computer or smartphone once NoviMedicine, a new telemedicine firm, launches its system for linking potential patients with dermatologists for remote diagnosis and treatment.
Clinicopathologic diagnosis minimizes misidentification of lymphoma
August 21st 2012Correctly diagnosing the many mimics of lymphoma requires consideration of both clinical and pathological findings, said Antonio Subtil, M.D., M.B.A., at the 2012 American Academy of Dermatology Summer Academy Meeting.
Nutritional deficiencies may precipitate vitiligo in children of color
August 21st 2012Promising breakthroughs in treating children of color include the discovery that nutritional deficiencies may have implications in vitiligo, said Nanette Silverberg, M.D., at the 2012 American Academy of Dermatology Summer Academy Meeting.
Consider melanoma, smoker's melanosis, when diagnosing pigmented oral lesions
August 21st 2012Clinicians cannot assume a patient who presents with oral pigmentation has a benign condition, due to endogenous and exogenous pigment that can reflect local and systemic process, says Ginat Mirowski, D.M.D., M.D., F.A.A.D., a dermatologist and professor of oral pathology, medicine and radiology, Indiana University School of Dentistry, Indianapolis.
Hand sanitizers deserve more recognition by dermatologists
August 21st 2012Hand sanitizers represent a new and perhaps underappreciated category of cosmeceutical, according to Zoe Draelos, M.D., a High Point, N.C., dermatologist in private practice and consulting professor, department of dermatology, Duke University School of Medicine, Durham, N.C.
Hot topic: Drug controversies involving finasteride, Zostavax
August 21st 2012Two of the hottest controversies in today’s dermatologic drug therapy involve medical concerns surrounding finasteride (Propecia, Merck) and Zostavax (zoster vaccine live, Merck), said Stephen E. Wolverton, M.D., at the 2012 American Academy of Dermatology Summer Academy Meeting.